Mihael Polymeropoulos
Chief Executive Officer bei VANDA PHARMACEUTICALS INC.
Vermögen: 8 Mio $ am 31.03.2024
Profil
Mihael Hristos Polymeropoulos is the founder of Vanda Pharmaceuticals, Inc. He founded the company in 2002 and currently holds the title of Chairman, President & Chief Executive Officer.
Dr. Polymeropoulos is also the founder of Integrated Molecular Analysis of Genome Expression.
Dr. Polymeropoulos's former job positions include Vice President & Head of the Pharmacogenetics Department at Novartis AG from 1998 to 2003, and Chief of the Gene Mapping Section at the National Human Genome Research Institute from 1992 to 1998.
In terms of education, Dr. Polymeropoulos completed his undergraduate degree at the University of Patras.
Bekannte Unternehmensbeteiligungen
Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
---|---|---|---|---|
05.03.2024 | 1 871 730 ( 3,25% ) | 8 Mio $ | 31.03.2024 |
Aktive Positionen von Mihael Polymeropoulos
Unternehmen | Position | Beginn |
---|---|---|
VANDA PHARMACEUTICALS INC. | Chief Executive Officer | 01.05.2003 |
Ehemalige bekannte Positionen von Mihael Polymeropoulos
Unternehmen | Position | Ende |
---|---|---|
NOVARTIS AG | Corporate Officer/Principal | 01.01.2003 |
National Human Genome Research Institute
National Human Genome Research Institute General GovernmentGovernment National Human Genome Research Institute engages in genetic and genomic research. It provides guidance to scientific programs and oversees the general operation. The company was founded in 1989 and is headquartered in Bethesda, MD. | Corporate Officer/Principal | 01.01.1998 |
Integrated Molecular Analysis of Genome Expression | Founder | - |
Ausbildung von Mihael Polymeropoulos
University of Patras | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 2 |
---|---|
VANDA PHARMACEUTICALS INC. | Health Technology |
NOVARTIS AG | Health Technology |
Private Unternehmen | 2 |
---|---|
Integrated Molecular Analysis of Genome Expression | |
National Human Genome Research Institute
National Human Genome Research Institute General GovernmentGovernment National Human Genome Research Institute engages in genetic and genomic research. It provides guidance to scientific programs and oversees the general operation. The company was founded in 1989 and is headquartered in Bethesda, MD. | Government |